Compare NWSA & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NWSA | ELAN |
|---|---|---|
| Founded | 2012 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Newspapers/Magazines | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.6B | 12.7B |
| IPO Year | N/A | 2018 |
| Metric | NWSA | ELAN |
|---|---|---|
| Price | $26.42 | $22.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $38.18 | $27.89 |
| AVG Volume (30 Days) | 2.9M | ★ 3.7M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.76% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | $6.06 | $8.21 |
| Revenue Next Year | $3.25 | $5.31 |
| P/E Ratio | $11.53 | ★ N/A |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $22.20 | $9.42 |
| 52 Week High | $31.61 | $27.72 |
| Indicator | NWSA | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 63.90 | 45.08 |
| Support Level | $25.80 | $22.17 |
| Resistance Level | $27.01 | $22.89 |
| Average True Range (ATR) | 0.56 | 0.73 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 70.92 | 32.62 |
News Corporation is a diversified media conglomerate with large presence in the US, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. Its 61%-owned REA Group is the dominant property listings platform in Australia. In addition, it owns Harper Collins, one of the largest book publishers in the world, and has a sizable US digital property advertising business, Move. The 65% interest in Foxtel, the Australian pay-TV and streaming provider, was sold in April 2025. The sale to global sports streaming platform, DAZN, was struck at more than 7 times Foxtel's EBITDA.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.